FDA OKs first seasonal flu vaccine made using animal cell cultures

11/20/2012 | Reuters

The FDA has approved the use of Novartis' seasonal influenza vaccine for people ages 18 and older. The vaccine, which will be marketed under the brand name Flucelvax, is the first seasonal flu vaccine produced using animal cell cultures instead of the traditional chicken egg method, which allows for a faster production process.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Education

Job Title Company Location
Technical Assistance Associate (8156)
American Institutes for Research
Washington, DC
Director, Curriculum & Content
Houghton Mifflin Harcourt
Nashville, TN
Senior Technical Assistance Consultant
American Institutes for Research
Washington, DC
Associate Account Executive
Houghton Mifflin Harcourt
Cheyenne, WY
Technical Assistance Consultant
American Institutes for Research
Washington, DC